Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hilal Taymaz-Nikerel

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Molecular Omics|July 19, 2021
Integration of fluxome and transcriptome data in <i>Saccharomyces cerevisiae</i> offers unique features of doxorubicin and imatinibHilal Taymaz-Nikerel
Turkish Journal of Biology = Turk Biyoloji Dergisi|August 3, 2023
Doxorubicin-induced transcriptome meets interactome: identification of new drug targetsHilal Taymaz-Nikerel
Microorganisms|January 21, 2022
<i>Vitreoscilla</i> Haemoglobin: A Tool to Reduce Overflow MetabolismHilal Taymaz-Nikerel, Alvaro R Lara
Frontiers in Bioengineering and Biotechnology|March 26, 2016
Editorial: Quantitative Systems Biology for Engineering Organisms and PathwaysHilal Taymaz-Nikerel, Alvaro R Lara
Omics : a Journal of Integrative Biology|September 29, 2020
Insights Into the Mechanism of Anticancer Drug Imatinib Revealed Through Multi-Omic Analyses in YeastHilal Taymaz-Nikerel, Serpil Eraslan, Betül Kırdar
Frontiers in Bioengineering and Biotechnology|March 1, 2016
Genome-Wide Transcriptional Response of Saccharomyces cerevisiae to Stress-Induced PerturbationsHilal Taymaz-Nikerel, Ayca Cankorur-Cetinkaya, Betul Kirdar
The Pharmacogenomics Journal|June 22, 2021
Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selectionArzu Cakir, Melisa Tuncer, Hilal Taymaz-Nikerel, et al.
Molecular Omics|June 7, 2021
Time-dependent re-organization of biological processes by the analysis of the dynamic transcriptional response of yeast cells to doxorubicinMuhammed Erkan Karabekmez, Hilal Taymaz-Nikerel, Serpil Eraslan, et al.
Metabolic Engineering|March 29, 2011
Escherichia coli responds with a rapid and large change in growth rate upon a shift from glucose-limited to glucose-excess conditionsHilal Taymaz-Nikerel, Walter M van Gulik, Joseph J Heijnen
Scientific Reports|September 14, 2018
Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cellsHilal Taymaz-Nikerel, Muhammed Erkan Karabekmez, Serpil Eraslan, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Molecular Omics|July 19, 2021
Integration of fluxome and transcriptome data in <i>Saccharomyces cerevisiae</i> offers unique features of doxorubicin and imatinibHilal Taymaz-Nikerel
Turkish Journal of Biology = Turk Biyoloji Dergisi|August 3, 2023
Doxorubicin-induced transcriptome meets interactome: identification of new drug targetsHilal Taymaz-Nikerel
Microorganisms|January 21, 2022
<i>Vitreoscilla</i> Haemoglobin: A Tool to Reduce Overflow MetabolismHilal Taymaz-Nikerel, Alvaro R Lara
Frontiers in Bioengineering and Biotechnology|March 26, 2016
Editorial: Quantitative Systems Biology for Engineering Organisms and PathwaysHilal Taymaz-Nikerel, Alvaro R Lara
Omics : a Journal of Integrative Biology|September 29, 2020
Insights Into the Mechanism of Anticancer Drug Imatinib Revealed Through Multi-Omic Analyses in YeastHilal Taymaz-Nikerel, Serpil Eraslan, Betül Kırdar
Frontiers in Bioengineering and Biotechnology|March 1, 2016
Genome-Wide Transcriptional Response of Saccharomyces cerevisiae to Stress-Induced PerturbationsHilal Taymaz-Nikerel, Ayca Cankorur-Cetinkaya, Betul Kirdar
The Pharmacogenomics Journal|June 22, 2021
Side effect prediction based on drug-induced gene expression profiles and random forest with iterative feature selectionArzu Cakir, Melisa Tuncer, Hilal Taymaz-Nikerel, et al.
Molecular Omics|June 7, 2021
Time-dependent re-organization of biological processes by the analysis of the dynamic transcriptional response of yeast cells to doxorubicinMuhammed Erkan Karabekmez, Hilal Taymaz-Nikerel, Serpil Eraslan, et al.
Metabolic Engineering|March 29, 2011
Escherichia coli responds with a rapid and large change in growth rate upon a shift from glucose-limited to glucose-excess conditionsHilal Taymaz-Nikerel, Walter M van Gulik, Joseph J Heijnen
Scientific Reports|September 14, 2018
Doxorubicin induces an extensive transcriptional and metabolic rewiring in yeast cellsHilal Taymaz-Nikerel, Muhammed Erkan Karabekmez, Serpil Eraslan, et al.
Pageof 3